The CIA's venture capital arm, In-Q-Tel, is revealed to have invested in SkinCentral Sciences, a company that developed a skin-exfoliating "pen." While marketed as a cosmetic tool for erasing blemishes, the technology's ability to remove the upper layer of skin makes it a potential tool for painless DNA collection.
